Uterine Fibroids

A uterine fibroid is a non-cancerous (benign) tumor that originates from the smooth muscle layer (myometrium) and the accompanying connective tissue of the uterus. Fibroids are the most common benign tumors in females and typically found during the middle and later reproductive years. While most fibroids are asymptomatic, they can grow and cause heavy and painful menstruation, painful sexual intercourse, and urinary frequency and urgency. Uterine fibroids are the major indication for hysterectomy in the US. Fibroids are often multiple and if the uterus contains too many leiomyomatas to count, it is referred to as uterine leiomyomatosis. The malignant version of a fibroid is uncommon and termed a leiomyosarcoma.


Fibroids are non-cancerous tumors within or around the uterine wall. Although they are often asymptomatic, it is important to know that depending on their size and location they can become troublesome and dangerous over time. Learn more.

Treatments & Options

Absent a diagnosis of cancer, most women do not need a hysterectomy to treat fibroids. The size and location of your fibroids, along with your medical history, will determine the options available to you. Take the time to learn about your treatment options.

Dr. Bartsich

Dr. Ernst Bartsich"The better informed you are when talking with your doctors, the easier it will be to evaluate their recommendations and make decisions."

The Other Choice

Dr. Ernst BartsichA comprehensive guide for women with fibroids. This book offers a complete description of the current situation with fibroids in the medical industry today. It covers alternatives, legalities and personal histories, as well as the opinions of several prominent physicians of OB/GYN. To order go to Xlibiris bookstore.


Thursday, March 26, 2015
VIVA physician selected as new Fellows in the Society of Interventional Radiology More...
Wednesday, March 25, 2015
Laparoscopic hysterectomy with morcellation safer than abdominal procedure for treating presumed fibroid uterus More...
Friday, March 13, 2015
BioSpecifics Technologies provides corporate update, reports Q4 and FY 2014 financial results More...
Friday, February 20, 2015
Study: Risk of uterine sarcoma fairly low in women following hysterectomy More...
Wednesday, February 18, 2015
Actavis provides overview of standalone global pharmaceutical development pipeline More...